Navigation Links
UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
Date:10/31/2007

UCLA's California NanoSystems Institute (CNSI) and the University of Tokyo's Center for NanoBio Integration (CNBI) will jointly sponsor an international symposium on nanobiotechnology at UCLA Nov. 12.

The CNSI-CNBI Symposium on NanoBiotechnology, which will be held in the auditorium of UCLA's new CNSI building, an 188,000-square-foot structure dedicated to nano-scale research, will feature keynote speakers from the Sidney Kimmel Cancer Center in San Diego, the National Cancer Institute's Alliance for Nanotechnology in Cancer, the Lawrence Berkeley National Laboratory and the National Science Foundation.

The symposium will begin with remarks from UCLA Chancellor Gene Block and University of Tokyo President Hiroshi Komiyama, followed by special presentations on biotechnology and biomedical topics by renowned researchers from the Japanese National Institute for Materials Science, the CNBI, the CNSI and the David Geffen School of Medicine at UCLA.

Nanobiotechnology has emerged in recent years as an important new field of research especially the area of nanomedicine. Nano-scale cancer research, for example, has produced new means of detection, diagnosis and drug delivery. Speakers from disciplines including biology, medicine, chemistry, physics and bioengineering will highlight such advances, which are transforming medical research today and are expected to have a dramatic impact on medical practices in the future.

A special panel discussion titled "Bridging the Gap: Bringing NanoBiology to the Healthcare Industry" will illuminate the importance of developing novel nanomaterials and nano-scale methods for biological research and medical application and will highlight the important research initiatives featured throughout the symposium.

The symposium, organized by CNSI member Fuyu Tamanoi, UCLA professor of microbiology, immunology and molecular genetics and director of the signal transduction and therapeutics program area at
'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. John Hopkins Hospitals- Now at Tokyo
2. Traders Smell Something Fishy in Tokyo Market Move
3. Armani to Launch First Spa in Tokyo
4. Researchers at Cornell University as been reported using research fund by false claims
5. A new study by John Hopkins University proposes formula for good health
6. James Cook University urges more medical seats
7. Pill splitting program of University of Michigan can save money
8. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
9. Yale University guidelines for Physicians and Pharmaceutical industry
10. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
11. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased to ... pans, ML-T balances give operators the room they need to carry out weighing ... makes ML-T balances a perfect choice for day-to-day weighing in nearly any analytical ...
(Date:7/1/2015)... ... July 01, 2015 , ... Northbound Treatment Services announced today ... Relations. , Emily originally entered the behavioral healthcare industry as an academic ... academic curriculum for clients to engage in their educational journey while in treatment. ...
(Date:7/1/2015)... City, UT (PRWEB) , ... July 01, 2015 ... ... compare the different philosophies and approaches to case management, placement, sober companionship and ... different training and approaches to working with and transporting clients with anxiety, ADHD, ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... southwest Georgia and the Florida Panhandle, the regional southeast Alabama community health ... messaging and clinical communications workflow solution provider. TelmedIQ, a burgeoning leader in ...
(Date:7/1/2015)... ... July 01, 2015 , ... Nutritional Products International, a brand focused ... products, recently attended the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, ... The ECRM trade show allows companies the chance to meet with a ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2
... under a ,Pay or Play, law, 10,entry-level employees will ... new study presented as,part of a Cornell University symposium ... provide health insurance to their employees or a pay,fine, ... the work,force., The study sponsored by the Employment ...
... success in helping children , FRIDAY, Nov. 9 (HealthDay ... juvenile rheumatoid arthritis, according to studies presented this week ... Boston. , One study found that abatacept, used to ... be a well-tolerated treatment for children and adolescents with ...
... 24 and Taclonex; Company ... financial guidance, ST. DAVID,S, Bermuda, Nov. 9 Warner Chilcott,Limited ... ended,September 30, 2007. Revenue in the quarter ended September 30, 2007 ... The,primary drivers of the increase in revenue were the net sales ...
... Del., Nov. 9 AstraZeneca (NYSE:,AZN) announced today ... has,approved CRESTOR(R) (rosuvastatin calcium) as an adjunct to ... with elevated cholesterol.,This new indication gives CRESTOR an ... "This new indication allows us to share what ...
... RURAL HALL, N.C., EXTON, Pa. and SAN DIEGO, ... a southeastern US,provider of oncology equipment sales and ... strategic alliance with Radiology Oncology Systems, Inc.,(ROS), an ... and Acceletronics, Inc., a US provider of oncology ...
... 8 State,Compensation Insurance Fund is presenting a ... Fund,s Employer Education Series, featuring its own,innovative and ... seminar entitled "Watch Your Back",introduces an educational and ... the very people they are trying to protect ...
Cached Medicine News:Health News:New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees 2Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 2Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 3Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 4Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 2Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 3
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: